10-Q Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001193125-17-164338`
Period End Date	20170331
Filing Date	20170509
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	nbix-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 32 Cash Flow Statement 48

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$74.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$115.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$83.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$64.09M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments, available for sale	`AvailableForSaleSecuritiesCurrent`	$171.49M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments, available for sale	`AvailableForSaleSecuritiesCurrent`	$224.08M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.87M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.09M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$239.45M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$310.44M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	86.88M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	87.52M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.27M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	87.52M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	86.88M	shares	Point-in-time
Long-term investments, available for sale	`AvailableForSaleSecuritiesNoncurrent`	$43.49M	USD	Point-in-time
Long-term investments, available for sale	`AvailableForSaleSecuritiesNoncurrent`	$37.69M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.08M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.88M	USD	Point-in-time
Total assets	`Assets`	$365.09M	USD	Point-in-time
Total assets	`Assets`	$289.36M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$852.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.08M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$21.10M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$18.40M	USD	Point-in-time
Current portion of cease-use liability	`CeaseUseLiabilityCurrent`	$236.00K	USD	Point-in-time
Current portion of cease-use liability	`CeaseUseLiabilityCurrent`	$243.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$470.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$513.00K	USD	Point-in-time
Current portion of deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateCurrent`	$3.55M	USD	Point-in-time
Current portion of deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateCurrent`	$3.53M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.56M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$30.41M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$6.47M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$7.37M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$1.46M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$1.30M	USD	Point-in-time
Cease-use liability	`CeaseUseLiabilityNoncurrent`	$617.00K	USD	Point-in-time
Cease-use liability	`CeaseUseLiabilityNoncurrent`	$544.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$113.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$113.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$42.22M	USD	Point-in-time
Total liabilities	`Liabilities`	$50.21M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 87,519,910 as of March 31, 2017 and 86,883,300 as of December 31, 2016	`CommonStockValue`	$88.00K	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 87,519,910 as of March 31, 2017 and 86,883,300 as of December 31, 2016	`CommonStockValue`	$87.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.37B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.38B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-318.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-235.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.13B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.06B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$314.88M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$247.14M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$365.09M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$289.36M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
License fees and milestones	`LicensesRevenue`	-	USD	1 Quarter
License fees and milestones	`LicensesRevenue`	$15.00M	USD	1 Quarter
Total revenues	`Revenues`	$15.00M	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$51.88M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$23.90M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$11.95M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$28.05M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$79.93M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$35.86M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-20.86M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-79.93M	USD	1 Quarter
Gain on sale/disposal of assets	`NonoperatingGainLossOnDispositionOfAssets`	-	USD	1 Quarter
Gain on sale/disposal of assets	`NonoperatingGainLossOnDispositionOfAssets`	$3.00K	USD	1 Quarter
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$853.00K	USD	1 Quarter
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$879.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$737.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$727.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.59M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-19.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.90	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	86.50M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	87.28M	shares	1 Quarter
Net loss	`NetIncomeLoss`	$-19.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Net unrealized gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$789.00K	USD	1 Quarter
Net unrealized gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$83.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-18.48M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-78.24M	USD	1 Quarter

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-19.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$276.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$489.00K	USD	1 Quarter
Gain on sale of assets	`GainsLossesOnSalesOfAssets`	$856.00K	USD	1 Quarter
Gain on sale of assets	`GainsLossesOnSalesOfAssets`	$879.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$-64.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$-114.00K	USD	1 Quarter
Cease-use expense	`IncreaseDecreaseInCeaseUseExpense`	$-584.00K	USD	1 Quarter
Cease-use expense	`IncreaseDecreaseInCeaseUseExpense`	-	USD	1 Quarter
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-269.00K	USD	1 Quarter
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.40M	USD	1 Quarter
Non-cash share-based compensation expense	`ShareBasedCompensation`	$6.92M	USD	1 Quarter
Non-cash share-based compensation expense	`ShareBasedCompensation`	$8.98M	USD	1 Quarter
Accounts receivable under collaboration agreements and other assets	`IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets`	$14.58M	USD	1 Quarter
Accounts receivable under collaboration agreements and other assets	`IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets`	$779.00K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.35M	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-6.93M	USD	1 Quarter
Cease-use liability	`IncreaseDecreaseInCeaseUseLiability`	$-110.00K	USD	1 Quarter
Cease-use liability	`IncreaseDecreaseInCeaseUseLiability`	$-66.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-77.36M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-29.21M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$57.88M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$55.56M	USD	1 Quarter
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$116.08M	USD	1 Quarter
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$126.75M	USD	1 Quarter
Deposits and restricted cash	`IncreaseDecreaseInRestrictedCash`	$200.00K	USD	1 Quarter
Deposits and restricted cash	`IncreaseDecreaseInRestrictedCash`	$200.00K	USD	1 Quarter
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$3.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.36M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$741.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$70.25M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$56.65M	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.53M	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$62.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$62.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.53M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$41.11M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-19.18M	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$74.19M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$115.30M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$83.27M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$64.09M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$74.19M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$115.30M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$83.27M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$64.09M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.